Document is current
Any future updates will be listed below
-
Authors
Stoelinga, Anna E. C. http://orcid.org/0000-0002-3110-924X
Tushuizen, Maarten E.
van den Hout, Wilbert B.
Girondo, Mar D. M. Rodriguez
de Vries, Elsemieke S.
Levens, Amar D.
Moes, Dirk-Jan A. R.
Gevers, Tom J. G.
van der Meer, Suzanne
Brouwer, Hans T.
de Jonge, Hendrik J. M.
de Boer, Ynte S.
Beuers, Ulrich H. W.
van der Meer, Adriaan J.
van den Berg, Aad P.
Guichelaar, Maureen M. J.
Drenth, Joost P. H.
van Hoek, Bart
,
Bakker, Sjoerd F.
Vrolijk, JM
van der Veek, Patrick
van Gerven, Nicole F.
-
Funding
Funding for this research was provided by:
ZonMw (10140022010001)
Chiesi Farmaceutici (PA 2019-71111/vjanssen)
- License Information
-
More Information
Article History
Received: 4 October 2023
Accepted: 24 November 2023
First Online: 17 January 2024
Declarations
:
: The study is conducted according to the principles of the Declaration of Helsinki and in accordance with Dutch Law on research with humans (Medical Research Involving Human Subject Act (WMO)). Central ethical approval has been confirmed from the medical research ethics committee of the Leiden University Medical Center on 13 December 2021. Important protocol modification will be communicated to the central and local ethics committees. Written, informed consent to participate will be obtained from all participants.
: Not required; the study results that will be published in the future will not contain any data from any individual person. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests. Although the LUMC pharmacy procures Envarsus at a discounted rate, this arrangement has no bearing on the study and is unrelated to the content of this manuscript.
